SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing a massive surge after a strong earnings report that outperformed estimates, with the community celebrating the company's ability to capitalize on AI data center demand. Investors are actively discussing a significant sector rotation into semiconductors, with many focused on the stock shattering long-term resistance levels while shorts face an intense squeeze.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging to all-time highs as traders capitalize on massive spillover momentum from Intel's strong quarterly results and broader semiconductor industry demand. The community remains intensely focused on the AI infrastructure buildout, with bulls eyeing continued price expansion driven by strong sector leadership and persistent institutional accumulation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are actively debating the sustainability of the semiconductor rally, with many expressing frustration over the persistent strength in chip stocks that continues to punish bearish positions. The ongoing discussion centers on whether the sector is experiencing a classic speculative bubble fueled by extreme AI demand and institutional inflows, or if a sharp, imminent correction is inevitable as traders look for any signs of a market pivot.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as investors aggressively position around the nuclear-AI nexus, fueled by a new federal initiative for space-based nuclear energy and the upcoming IPO of peer X-Energy. The community is focused on the stock's parabolic technical breakout, intense institutional accumulation, and the high-stakes battle to clear critical resistance levels as sentiment shifts to reflect nuclear power as a mandatory infrastructure requirement for AI compute.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc. is surging after a federal jury ruled in its favor, awarding $420 million in damages regarding deceptive advertising and the use of bots by a rival, with potential for even greater profit disgorgement. Community sentiment is electric, with investors actively debating the long-term impact of the windfall on the companys cash position and the potential for a massive, multi-day short squeeze as traders monitor for after-hours momentum.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant momentum driven by the introduction of its new AGI CPU, a strategic shift that marks its transition from traditional IP licensing to direct silicon sales. The community is actively debating the sustainability of this aggressive repricing, with bullish investors highlighting the company's expanding role as a foundational AI infrastructure player, while skeptics warn of valuation risks following the rapid, volume-heavy breakout.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Investors are sharply divided over SOXL's historic, multi-week rally, with bulls citing a semiconductor "super-cycle" driven by insatiable AI infrastructure demand, while bears warn of a speculative "blow-off top" and unsustainable euphoria. Community discussions are dominated by the intense psychological battle between those riding the momentum to new highs and others aggressively hedging with inverse ETFs, all while monitoring key upcoming earnings catalysts.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is experiencing intense volatility as investors react to the Department of Justice's announcement to reclassify cannabis to Schedule III, a move expected to provide significant tax relief and improve banking access. While some in the community are celebrating this as a landmark shift, others are expressing frustration over the stock's sharp price swings and long-term dilution concerns, leading to active debates on whether this is a sustainable breakout or another 'sell-the-news' event.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors anticipate a major partnership announcement involving Ripple and prepare for industry events in Las Vegas, driving significant community excitement regarding its utility in real-time payroll and payment infrastructure. While some users express frustration over volatility and supply volume, bulls remain focused on the potential for institutional adoption and recent technical breakout patterns.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as the community rallies around hopes of a major comeback, fueled by anticipation of Binance burn initiatives and potential exchange relistings. Investors are actively discussing the project's underdog status and speculative potential, with many pinning their hopes on future community-driven development and a return to past valuation levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innate Pharma to Participate in the D. Boral Capital Global Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in one-on-one investor meetings at the following...

Innate Pharma to Present MATISSE Phase 2 Interim Results of IPH5201 in Clinical Trials Plenary Session at AACR 2026

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announced that interim results from the MATISSE Phase 2 study evaluating IPH5201 in combination...

Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 9.3% - Here's What Happened

Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 9.3% - Time to Buy...

Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026

Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...

HC Wainwright Decreases Earnings Estimates for Innate Pharma

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Stock analysts at HC Wainwright decreased their FY2026 earnings per share (EPS) estimates for shares of Innate Pharma in a report released on Tuesday, April 7th. HC Wainwright analyst S. Ramakanth now anticipates that the company will po...

Brokers Set Expectations for Innate Pharma FY2030 Earnings

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Equities researchers at HC Wainwright issued their FY2030 EPS estimates for Innate Pharma in a research report issued on Tuesday, April...

Innate Pharma to Present at the AACR 2026 Oncology Industry Partnering Event

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ('Innate' or the 'Company'), announced today that Yannis Morel, Chief Operating Officer, will present at the AACR Oncology...

Innate Pharma (NASDAQ:IPHA) Given "Buy" Rating at HC Wainwright

HC Wainwright reaffirmed a "buy" rating and issued a $5.00 price objective on shares of Innate Pharma in a research note on Tuesday...

Innate Pharma to Participate in the Kempen Life Sciences Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced...

Innate Pharma Files Its 2025 Universal Registration Document (Document Denregistrement Universel) and 2025 Form 20-f Annual Report

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced the filing of its 2025 Universal Registration Document (Document denregistrement...

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.

Current Price	$1.37
Prev Close	$1.43
Open	$1.44
Dividend Yield	0.00%
50-Day Moving Average	$1.52
Beta	0.54
Avg. Volume	21,694.41
PE Ratio	-2.33

52-Week High	$2.63
52-Week Low	$1.17
Market Capitalization	$134.14M
EPS (Annual)	-$0.6195
Price to Book	-5.26
Revenue Per Employee	$19,296.61

IPHA
Innate Pharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IPHA News

IPHAInnate Pharma